Executive Interviews
Austpac Resources N.L. (ASX:APG) – CEO Interview
Austpac Resources N.L. is a minerals technology company which has developed new commercial processes for the titanium, steel and iron ore industries. Austpac is listed on the Australian Stock Exchange (ASX Code: APG). APG has developed mineral technologies that are applicable to the steel and titanium metal industries. The Company’s facility at Kooragang Island has […]
Viralytics Ltd (ASX:VLA) – CEO Interview
Viralytics is an Australian Stock Exchange listed company developing a portfolio of Oncolytic viruses that have the potential not only to provide a more effective treatment of a range of cancers, but also a substantial improvement in patients quality of life. Focused on developing oncolytic virotherapy for the treatment of a wide range of cancers […]
Rental Management Investment Trust – CEO Interview
The primary purpose of the Rental Management Investment Trust (RMIT) is to invest in the Rental Management Australia Fund (RMA Fund). The RMA Fund is an unlisted stapled investment comprising of the Rental Management Australia Group Ltd (RMA Group) and the Rental Management Australia Trust (RMA Trust).
Bio-Gene Technology Limited – CEO Interview
Bio-Gene Technology is a W.A. biotech company that has discovered a natural organic insecticide in the leaves of an Australian Eucalypt tree called Qcide. Qcide produces 100% mortality in insects yet is non-toxic to mammals, birds, and reptiles making it a very safe and effective alternative to some compounds in the world today.
Cellmid Ltd – CEO Interview
Cellmid (ASX: CDY) develops innovative therapies and diagnostics for cancer, inflammation and heart attack. CDY has the largest global IP portfolio related to growth factor midkine (MK). Its most advanced program is for MK antibodies targeting cancer/inflammation. CDY is also developing MK protein to treat heart attack and other ischemia.
Wizard Power Pty Ltd – CEO Interview
Wizard Power develops world leading Concentrating Solar Power (CSP) technology and licenses it to developers of large-scale energy projects. Its core product is the Big Dish, a multi-purpose, ultra high temperature solar energy delivery platform that provides the world’s most competitive on-demand utility scale solar energy. Aside from electricity generation, it also provides energy for […]
Optiscan Imaging – CEO Interview
Optiscan is a global leader in the development and application of miniaturised microscopic imaging technologies for medical markets. Optiscan’s imaging technology allows live cellular imaging for earlier and better detection of pre-cancerous and cancerous lesions and more accurate resection during surgery. Optiscan’s technology has been incorporated into Pentax endoscopes since 2006 and will soon be […]
BioSyngas – CEO Interview
Over the past four years, Syngas Limited (ASX:SYS) has invested in and established a biomass/clean energy business (BioSyngas Pty Ltd) on the basis that commercial opportunities would be created through the introduction of carbon management initiatives in Australia. Syngas has now reached the stage where a separate entity, BioSyngas Pty Ltd, is ready to launch, […]
Capita Asset Management – CEO Interview
Capita Asset Management Limited is a Brisbane based funds management company specialising in property syndicates and mortgage lending. The company’s latest investment offer is the ‘Capita Adelaide Street Trust’ which is being formed to acquire and develop an approved 8 Lot residential subdivision in Clayfield, Brisbane.
Backed By Leading Investment Groups and Family Offices
